Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-7-1
|
pubmed:abstractText |
Wegener's autoantigen (WA), a 29 kD multifunctional protein, is the principal target antigen of autoantibodies associated with Wegener's granulomatosis (WG). WA was first identified as proteinase 3 (PR3), which is now known to be identical with myeloblastin and AGP7. Like other lysosomal proteins, WA/PR3 displays enzymatic activity, differentiation factor activity for myeloid precursor cells, and antimicrobial functions. Neutrophilic polymorphonuclear leukocytes (PMN) and a subpopulation of monocytes contain high levels of WA/PR3 in their myeloperoxidase-positive granules. The autoantibodies from WG sera produce a finely granular, centrally accentuated fluorescence pattern on PMN and monocytes and have been designated 'classic' pattern antineutrophil cytoplasmic autoantibodies (cANCA). However, PMN/monocyte activation (in vitro/ex vivo) is associated with the translocation of WA/PR3 on the cytoplasm membrane. WA/PR3 is accessible to the WG-associated autoantibody: cANCA stimulate cytokine-preactivated PMN to produce oxygen radicals and to degranulate. Furthermore, cANCA interfere with the biological functions of WA/PR3 (e.g. inhibition of elastinolytic activity). Hence, cANCA represents not only the best seromarker for WG so far available, but several lines of evidence indicate that the autoantibodies against WA/PR3 play a major role in the pathogenesis of this enigmatic disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antineutrophil...,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloblastin,
http://linkedlifedata.com/resource/pubmed/chemical/Peroxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0896-8411
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171-84
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8388690-Amino Acid Sequence,
pubmed-meshheading:8388690-Antibodies, Antineutrophil Cytoplasmic,
pubmed-meshheading:8388690-Autoantibodies,
pubmed-meshheading:8388690-Autoantigens,
pubmed-meshheading:8388690-Autoimmune Diseases,
pubmed-meshheading:8388690-Base Sequence,
pubmed-meshheading:8388690-Cytoplasm,
pubmed-meshheading:8388690-Fluorescent Antibody Technique,
pubmed-meshheading:8388690-Humans,
pubmed-meshheading:8388690-Molecular Sequence Data,
pubmed-meshheading:8388690-Myeloblastin,
pubmed-meshheading:8388690-Neutrophils,
pubmed-meshheading:8388690-Peroxidase,
pubmed-meshheading:8388690-Serine Endopeptidases,
pubmed-meshheading:8388690-Vasculitis,
pubmed-meshheading:8388690-Wegener Granulomatosis
|
pubmed:year |
1993
|
pubmed:articleTitle |
'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
|
pubmed:affiliation |
Medical University in Lübeck, Department of Clinical Rheumatology, and Rhemaklinik Bad Bramstedt, Germany.
|
pubmed:publicationType |
Journal Article,
Review
|